[{"id":"80508af6-7ecc-4d80-9db9-bae1a12b6cde","acronym":"","url":"https://clinicaltrials.gov/study/NCT05168423","created_at":"2021-12-23T16:53:41.350Z","updated_at":"2024-07-02T16:35:20.694Z","phase":"Phase 1","brief_title":"CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM","source_id_and_acronym":"NCT05168423","lead_sponsor":"University of Pennsylvania","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR amplification • EGFR wild-type • IDH wild-type","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR amplification • EGFR wild-type • IDH wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • TmEGFR/IL13Rα2 01 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 02/24/2023","start_date":" 02/24/2023","primary_txt":" Primary completion: 12/19/2024","primary_completion_date":" 12/19/2024","study_txt":" Completion: 12/19/2039","study_completion_date":" 12/19/2039","last_update_posted":"2024-02-06"}]